NASDAQ · Medical - Devices

INMD (INMD) Stock

$15.38 +1.38% NASDAQ: INMD Healthcare

Valuation

MetricValue
Price$15.38
Market Cap$884.05M
P/E Ratio9.72
P/B Ratio1.29
P/S Ratio2.38
EPS (TTM)$1.43
52-Week High$16.74
52-Week Low$12.72
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE13.76%
ROA12.27%
ROCE12.45%
Gross Margin22.97%
Operating Margin22.97%
Net Margin23.27%
Debt/Equity0.01
Current Ratio9.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$358.0M$454.0M$492.0M$395.0M$370.0M
Operating Profit$167.0M$198.0M$196.0M$113.0M$85.0M
Net Profit$165.0M$162.0M$198.0M$181.0M$94.0M
EPS$1.92$1.89$2.30$2.25$1.43
Op Margin46.8%43.5%39.8%28.5%23.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$479.0M$644.0M$863.0M$786.0M$766.0M
Total Liabilities$63.0M$90.0M$76.0M$82.0M$83.0M
Cash$68.0M$98.0M$144.0M$155.0M$303.0M
Borrowings$5.0M$5.0M$9.0M$8.0M$13.0M

Latest News

Sector Update: Health Care Stocks Lower Early Monday MT Newswires · Jul 13, 2026 Sector Update: Healthcare MT Newswires · Jul 13, 2026 Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Renewed US-Iran Conflict Lifts Oil Prices MT Newswires · Jul 13, 2026 InMode Reports Preliminary Q2 Revenue MT Newswires · Jul 13, 2026 InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M PR Newswire · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$175.0M$182.0M$177.0M$133.0M$85.0M
Investing Cash Flow$-161.0M$-111.0M$-137.0M$162.0M$185.0M
Financing Cash Flow$-35.0M$-41.0M$6.0M$-283.0M$-127.0M
Net Cash Flow$-1.0M$29.0M$47.0M$11.0M$147.0M
Free Cash Flow$174.0M$180.0M$176.0M$132.0M$84.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA6.87
FCF Yield10.15%
Quick Ratio7.88
Interest Coverage—
Return 1Y1.07%
Return 3Y-66.19%
Return 5Y-70.88%

Ownership

Insiders Held13.14%
Institutions Held59.23%
Institutions Float Held68.19%
Institutional HolderSharesReport Date
Doma Perpetual Capital Management LLC3,067,4312026-03-31
Acadian Asset Management. LLC2,593,2032026-03-31
Renaissance Technologies, LLC2,586,2182026-03-31
Blackrock Inc.2,254,7292026-03-31
Menora Mivtachim Holdings Ltd.2,040,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
ANAB $53.61 -1.00% -127.70 $2.31B 0.00%
AXGN $40.48 +2.51% 60.40 $2.15B 0.00%
CTEVClaritev Corporation $21.73 +0.56% -1.25 $370.45M 0.00%
IART $19.76 +1.15% 5.27 $1.54B 0.00%

About INMD

INMD is led by CEO Moshe Mizrahy, publicly traded since 2019.

INMD stock trades at $15.38 with a market capitalization of $884.05M. The stock is valued at a price-to-earnings (P/E) ratio of 9.72, price-to-book of 1.29, price-to-sales of 2.38. Over the past 52 weeks the stock has ranged between $12.72 and $16.74, and currently trades 8.1% below its 52-week high.

On profitability, INMD generates a return on equity (ROE) of 13.76%, above the typical market average, return on capital employed of 12.45%, an operating margin of 22.97%, a net profit margin of 23.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides